Abstract
A strategy that combines virtual screening and structureguided selection of fragments was used to identify three unexplored classes of human DHODH inhibitor compounds: 4-hydroxycoumarins, fenamic acids, and N-(alkylcarbonyl)anthranilic acids. Structure-guided selection of fragments targeting the inner subsite of the DHODH ubiquinone binding site made these findings possible with screening of fewer than 300 fragments in a DHODH assay. Fragments from the three inhibitor classes identified were subsequently chemically expanded to target an additional subsite of hydrophobic character. All three classes were found to exhibit distinct structure–activity relationships upon expansion. The novel N-(alkylcarbonyl anthranilic acid class shows the most promising potency against human DHODH, with IC50 values in the low nanomolar range. The structure of human DHODH in complex with an inhibitor of this class is presented.
Original language | English |
---|---|
Pages (from-to) | 608-617 |
Journal | ChemMedChem |
Volume | 5 |
Issue number | 4 |
DOIs | |
Publication status | Published - 2010 |
Bibliographical note
The information about affiliations in this record was updated in December 2015.The record was previously connected to the following departments: Organic chemistry (S/LTH) (011001240), Biochemistry and Structural Biology (S) (000006142)
Subject classification (UKÄ)
- Pharmaceutical Sciences
Free keywords
- Dihydroorotate dehydrogenase
- drug discovery
- fragment screening
- inhibitors
- structure-activity relationships